Basel Medical Group Ltd Ordinary Shares (NASDAQ:BMGL) — Market Cap & Net Worth
Market Cap & Net Worth: Basel Medical Group Ltd Ordinary Shares (BMGL)
Basel Medical Group Ltd Ordinary Shares (NASDAQ:BMGL) has a market capitalization of $11.84 Million ($11.84 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26634 globally and #5483 in its home market, demonstrating a 5.95% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Basel Medical Group Ltd Ordinary Shares's stock price $0.63 by its total outstanding shares 18785750 (18.79 Million). Review debt load of Basel Medical Group Ltd Ordinary Shares to assess the company's total debt and financial obligations.
Basel Medical Group Ltd Ordinary Shares Market Cap History: 2025 to 2026
Basel Medical Group Ltd Ordinary Shares's market capitalization history from 2025 to 2026. Data shows growth from $9.21 Million to $11.84 Million (0.00% CAGR).
Index Memberships
Basel Medical Group Ltd Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.00% | #763 of 976 |
Weight: Basel Medical Group Ltd Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Basel Medical Group Ltd Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Basel Medical Group Ltd Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.81x
Basel Medical Group Ltd Ordinary Shares's market cap is 0.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $9.21 Million | $11.32 Million | -$12.09 Million | 0.81x | N/A |
Competitor Companies of BMGL by Market Capitalization
Companies near Basel Medical Group Ltd Ordinary Shares in the global market cap rankings as of June 17, 2026.
Key companies related to Basel Medical Group Ltd Ordinary Shares by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1003 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.53 Billion USD ( €21.84 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1333 globally with a market cap of $19.50 Billion USD ( RM77.67 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $396.93 |
| #1003 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.53 Billion | €38.77 |
| #1333 | IHH Healthcare Bhd | KLSE:5225 | $19.50 Billion | RM8.79 |
Basel Medical Group Ltd Ordinary Shares Historical Marketcap From 2025 to 2026
Between 2025 and today, Basel Medical Group Ltd Ordinary Shares's market cap moved from $9.21 Million to $ 11.84 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $11.84 Million | +28.57% |
| 2025 | $9.21 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Basel Medical Group Ltd Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.84 Million USD |
| MoneyControl | $11.84 Million USD |
| MarketWatch | $11.84 Million USD |
| marketcap.company | $11.84 Million USD |
| Reuters | $11.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental he… Read more